Codexis, Inc. (CDXS)
1.865
-0.06
(-2.86%)
USD |
NASDAQ |
Dec 09, 16:00
1.865
0.00 (0.00%)
Pre-Market: 20:00
Codexis Profit Margin (Quarterly): -228.1% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 33.68% |
| EyePoint Pharmaceuticals, Inc. | -6.18K% |
| Tarsus Pharmaceuticals, Inc. | -10.60% |
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -112.5% |
| Return on Assets | -46.46% |
| Return on Invested Capital | -54.85% |
| Gross Profit Margin (Quarterly) | 56.02% |
| Operating Margin (Quarterly) | -220.3% |
| Return on Net Operating Assets | -105.0% |